INTERNATIONAL PATENT: JANSSEN PHARMACEUTICA NV FILES APPLICATION FOR "TRIAZOLO[4,5-B]PYRIDINE COMPOUNDS USEFUL AS INHIBITORS OF WERNER SYNDROME RECQ HELICASE (WRN)"

GENEVA, Aug. 25 -- JANSSEN PHARMACEUTICA NV (Turnhoutseweg 302340 Beerse) filed a patent application (PCT/IB2025/051620) for "TRIAZOLO[4,5-B]PYRIDINE COMPOUNDS USEFUL AS INHIBITORS OF WERNER SYNDROME RECQ HELICASE (WRN)" on Feb 14, 2025. With publication no. WO/2025/172934, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DERATT, Lindsey (1400 McKean Rd, Spring HousePennsylvania 19477), KUDUK, Scott (1400 McKean Rd, Spring HousePennsylvania 19477), WALL, Mark (1400 McKean Rd, Spring HousePennsylvania 19477), KINNEY, R Garr...